The Institute for Peptide Therapy is an emerging European body convening clinicians, researchers and educators around peer exchange, professional education, clinical governance and the future of therapeutics. It will support the forthcoming Journal for Peptide Therapy, a monthly publication addressing clinically relevant advances from around the world.
Independence statement: The Institute is independent of medicinal-product manufacturers, marketing-authorisation holders, compounders, pharmacies and distributors. It receives no remuneration, referral fees, commissions or other financial benefit contingent upon the prescribing, purchasing or use of any medicinal product or peptide.
Welcome
Our remit
A considered space for clinicians and researchers to convene, compare practice and learn from one another.
Structured learning resources and continuing professional development for qualified practitioners.
Frameworks, standards and reflective tools that support safe, accountable and ethical practice.
Curating literature, supporting investigators and convening dialogue around emerging evidence.
A long-view forum for the scientific, regulatory and societal questions shaping the field.
A monthly editorial review of clinically relevant developments in peptide therapy, published under the Institute.
Education pathway
A structured postgraduate education pathway in therapeutic peptides, for healthcare professionals seeking an evidence-based understanding of one of the fastest-evolving areas of modern medicine. Programmes are organised around professional development — scientific integrity, clinical reasoning and the responsible governance of emerging therapies — rather than around individual compounds.
All programmes are delivered in English and suitable for an international audience. Additional language editions may follow.
Foundation programme
Clinical integration across domains
Our foundational Professional Certificate in Peptide Therapy, covering the science, regulatory landscape, evidence and clinical use of therapeutic peptides today. The programme explores these therapies in an educational, non-promotional context.
20% discount off the full course fee
Foundation programme
Foundations in biology, pharmacology and pharmaceutical science
The scientific foundations of therapeutic peptides, without clinical implementation. Suitable for healthcare professionals, scientists, pharmacists, nurses, researchers and students wishing to understand peptide biology from first principles.
Foundation programme
Clinical foundations and evidence-based reasoning
The Clinical Gateway module: the why and how peptides have moved into clinical practice. Rather than focusing on individual compounds, participants learn how experienced clinicians evaluate emerging therapies when the evidence is evolving.
A focused short-domain certificate exploring obesity, metabolic syndrome, insulin resistance, incretin biology and emerging metabolic therapies through current scientific evidence and clinical reasoning.
Register interest to be notified when enrolment opens.
Age-related anabolic decline, sarcopenia, muscle preservation and the physiology of healthy ageing.
The biology of tissue healing, musculoskeletal recovery and regenerative mechanisms, examined through current evidence and clinical reasoning.
Immune signalling, immunosenescence, inflammatory regulation and host defence — examined through current evidence and clinical reasoning.
Biological ageing science, cellular senescence, longevity biology and the responsible evaluation of evidence in an unusually hype-prone field.
Neuroplasticity, cognition, mood, sleep, neuroprotection and the careful evaluation of emerging neurological evidence.
Educational philosophy
Presenting evidence honestly, including its strengths and limitations.
Developing structured approaches to evaluating emerging therapies.
Emphasising governance, ethics and responsible professional practice.
Peptide science continues to evolve and requires continual critical appraisal.
Our programmes are educational in nature. They are designed to improve scientific understanding and professional knowledge. They do not provide prescribing advice or recommend the use of any specific medicinal product. Clinical decisions remain the responsibility of individual healthcare practitioners practising within their professional scope and applicable national laws.
What our students told us
End-of-course survey feedback indicates strong clinical relevance, evidence support and ease of use. The figures and comments below are drawn directly from anonymised graduate responses.
97.7%
found the content relevant to clinical practice
97.7%
found the content supported by peer-reviewed literature
90.7%
found the course and learning platform user friendly
“Excellent coverage of peptide essentials.”
— Graduate feedback
“As a new clinician in this field I find it very helpful especially the use of case studies, it helps to use the knowledge given in a clinical presentation.”
— Graduate feedback
“I found the case presentations extremely educational, well thought out and reinforced a practical approach.”
— Graduate feedback
“Fabulous course.”
— Graduate feedback
What students valued
Clinical case presentations and the translation of peptide science into practical clinical decision making.
Evidence-informed scientific content combined with practical clinical application.
Enquiries
For general, academic, editorial or professional enquiries, please use the form. A formal contact channel will be announced in due course; messages received here will be reviewed by the Institute.
Please do not include patient-identifiable information or requests for clinical advice.